Join Now

Yearly Archives: 2025

Lessons in Innovation: Clark Turner’s Impact on Medical Imaging

By Natalie Themm | Published May 29, 2025

Lessons in Innovation: Clark Turner’s Impact on Medical Imaging

Posted in BioUtah News | Tagged | Comments Off on Lessons in Innovation: Clark Turner’s Impact on Medical Imaging

Merit Medical Acquires Biolife Delaware

By admin | Published May 22, 2025

Acquired business offers the StatSeal® and WoundSeal® products, which provide hemostasis solutions that complement the wide range of procedures Merit’s portfolio supports. Acquisition projected to add approximately $18 million of revenue, on an annualized basis beginning in fiscal year 2026, with a mid-teens growth and accretive non-GAAP margin and profitability profile Merit reaffirms full-year 2025 […]

Posted in BioUtah News | Comments Off on Merit Medical Acquires Biolife Delaware

Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI

By Natalie Themm | Published May 22, 2025

Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI

Posted in BioUtah News | Tagged | Comments Off on Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI

BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies

By admin | Published May 15, 2025

New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma

Posted in BioUtah News | Tagged | Comments Off on BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies

KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging

By admin | Published May 15, 2025

Visit ISMRM Booth H19 for Hands-On Demonstrations of the KyphoLift™ and KyphoWedge™ Systems

Posted in BioUtah News | Tagged | Comments Off on KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging

Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills

By admin | Published May 8, 2025

BioUtah president and CEO, Kelvyn Cullmore, recently penned an op-ed published in the Deseret News.

Posted in BioUtah News | Tagged | Comments Off on Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills

Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis

By admin | Published May 8, 2025

The WRAPSODY CIE is designed to help physicians prolong functional vascular access in hemodialysis patients.

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis

Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial

By admin | Published May 8, 2025

In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months.

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology

By admin | Published May 8, 2025

Study suggests that utilizing RiskScore drives breast cancer screening tailored to individual risk

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology

EDWARDS TAVR RECEIVES FDA APPROVAL FOR PATIENTS WITH ASYMPTOMATIC SEVERE AORTIC STENOSIS

By Natalie Themm | Published May 1, 2025

Transforming Care for Severe AS Patients

Posted in BioUtah News | Tagged | Comments Off on EDWARDS TAVR RECEIVES FDA APPROVAL FOR PATIENTS WITH ASYMPTOMATIC SEVERE AORTIC STENOSIS

Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics

By Natalie Themm | Published May 1, 2025

Enhanced platform technology and the addition of a robust, high-quality CHO K-1 cell line decreases lead time to Investigational New Drug (IND)

Posted in BioUtah News | Tagged | Comments Off on Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics

Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting

By Natalie Themm | Published May 1, 2025

Podium presentation showcases the clinical application of Precise™ MRD

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting

A Special Thanks To Our Legacy and Platinum Elite Members